Table 3 IgG prevalence to MSP2, EBA-175 and PfRh2a Plasmodium falciparum based on age group

0-12 years

31.82%

1.07

32.73%

3.61

36.36%

1.49

(n = 110)

(0.40-2.76)

(1.97-7.47)

(0.78-2.78)

13-40 years

37.30%

1.41

38.10%

3.84

33.33%

1.49

(n = 126)

(0.74-3.78)

(2.44-9.27)

(1.01-3.05)

>40 years

42.86%

1.74

40.82%

3.38

36.73%

1.49

(n = 49)

(0.40-4.29)

(2.21-8.59)

(0.78-2.78)

p (ROH) (Kruskall Wallis test)

0.15

0.31

0.66

p (Spearman Correlation)

0.07

0.31

0.97